By Monica E. Oss Treatment of serious mental illnesses has improved over the course of my career—but there is still a long way to go. For consumers with schizophrenia, only 14.3% received care that could be considered consistent with evidence-based treatment recommendations (see Recent Care Of Common Mental Disorders In The United States ). For consumers participating in treatment, 25% to 60% are adherent with the recommended treatment plan (see Treatment Nonadherence In Schizophrenia: The Patient’s Perspective) and 80% to 90% of consumers treated for schizophrenia experience a relapse (see The Nature Of Relapse In Schizophrenia). One byproduct of the current state of treatment…
Content Restricted

This article is reserved for members with an active membership. Please register for a Free Membership to view this resource.

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!